The first antimalarial developed specifically for babies is a step closer to reaching parts of the world where malaria is endemic. The World Health Organization has completed its review of …
Health
-
-
As consumers, we’ve gotten used to a world that excels at last-mile logistics. Our socks arrive from Amazon the next day. That DoorDashed dinner shows up in 35 minutes. We …
-
The way the healthcare industry thinks about interoperability doesn’t capture the whole story. Interoperability is often described as ensuring that the right participants can access the right patient information at …
-
Legacy patient support is no longer fit for purpose. For too long, fragmented manual systems have created data silos and delays, leading to lower adherence rates and refills, decreased patient …
-
Oncology remains one of the most innovative and rapidly advancing fields in medicine. From chemotherapy to immunotherapy to the rise of personalized treatment, each breakthrough has brought us closer to …
-
When James Van Der Beek announced he had been diagnosed with colorectal cancer, it was the kind of news that stunned many of us. I grew up watching Dawson’s Creek, …
-
Biotechnology-focused venture capital firm Kurma Partners has closed a new fund with €215 million (about $252 million) in fresh capital to deploy across up to 20 young companies in the …
-
About 12% of claims were denied in 2024, leading to $262 billion in lost revenue to providers. Providers spend about $26 billion annually in recovering denied claims, but only 70% …
-
The GLP-1 craze is undeniable, with advertising for the injectables flooding our screens and public spaces, restaurants offering GLP-1-friendly menus, and providers restructuring care models around their use. About 12% …
-
During a fireside chat at the Medicarians Conference in Las Vegas on Tuesday, SCAN Health Plan CEO Sachin Jain made a plea to brokers: Drop the for-profit plans that treat …